VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹216 Cr | ₹171 Cr | ₹143 Cr | ₹116 Cr | ₹75 Cr |
What is the latest Appropriations of VENUS REMEDIES ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹216 Cr |
| Mar2024 | ₹171 Cr |
| Mar2023 | ₹143 Cr |
| Mar2022 | ₹116 Cr |
| Mar2021 | ₹75 Cr |
How is Appropriations of VENUS REMEDIES Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹216 Cr | 26.45 | |
| Mar2024 | ₹171 Cr | 19.66 | |
| Mar2023 | ₹143 Cr | 23.16 | |
| Mar2022 | ₹116 Cr | 54.06 | |
| Mar2021 | ₹75 Cr | - | |
Compare Appropriations of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹912.2 Cr | -11.6% | -10.4% | 130% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -11.6% |
-10.4% |
130% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses